1)総務省:平成24年版情報通信白書. http://www.soumu.go.jp/johotsusintokei/whitepaper/h24.html
2)葛谷雅文:高齢者診療におけるサルコペニアと虚弱の考え方.Mod Physician 31:1288-1291, 2011
3)Rosenberg IH:Summary comments. Am J Clin Nutr 50:1231-1233, 1989
4)Cruz-Jentoft AJ, et al:Sarcopenia:European consensus on definition and diagnosis─Report of the European Working Group on Sarcopenia in older people. Age and Aging 39:412-423, 2010
5)Baumgartner RN, et al:Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755-763, 1998
6)Sanada K, et al:A cross-sectional study of sarcopenia in Japanese men and women;Reference values and association with cardiovascular risk factors. Euro J Appl Physiol 110:57-65, 2010
7)Chen LK, et al:Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95-101, 2014
8)Park SW, et al:Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes:the health, aging, and body composition study. Diabetes Care 30:1507-1512, 2007
9)Heber D, et al:Clinical detection of sarcopenic obesity by bioelectorical impedance analysis. Am J Clin Nutr 64:472-477, 1996
10)Cesari M, et al:Sarcopenia, obesity, and inflammation-results from the Trial of Ansiontensin Converting Enzyme Inhibition and Novel Cardiovascular risk factor study. Am J Clin Nutr 82:919-925, 2007